Strippoli, Antonia
 Distribuzione geografica
Continente #
NA - Nord America 1.210
EU - Europa 1.204
AS - Asia 510
SA - Sud America 73
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.016
Nazione #
US - Stati Uniti d'America 1.199
DE - Germania 349
SE - Svezia 257
IT - Italia 253
SG - Singapore 167
CN - Cina 161
IN - India 83
BR - Brasile 65
FR - Francia 58
IE - Irlanda 51
GB - Regno Unito 41
ID - Indonesia 31
FI - Finlandia 30
RU - Federazione Russa 30
UA - Ucraina 30
PL - Polonia 23
TR - Turchia 21
BE - Belgio 19
IR - Iran 14
CI - Costa d'Avorio 13
NL - Olanda 13
CZ - Repubblica Ceca 9
KR - Corea 9
AT - Austria 8
CH - Svizzera 8
CA - Canada 6
LT - Lituania 6
HK - Hong Kong 5
MX - Messico 4
RO - Romania 4
BD - Bangladesh 3
ES - Italia 3
PT - Portogallo 3
VN - Vietnam 3
CL - Cile 2
DK - Danimarca 2
EC - Ecuador 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
NO - Norvegia 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
KW - Kuwait 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
Totale 3.016
Città #
Chandler 234
Ashburn 113
Singapore 108
New York 58
Cattolica 48
Dublin 48
Ann Arbor 46
Rome 42
San Mateo 39
The Dalles 38
Chicago 37
Wilmington 37
Hyderabad 33
Jakarta 31
Fairfield 29
Milan 28
Nanjing 24
Houston 23
Jacksonville 23
Warsaw 23
Dearborn 22
Boston 20
Moscow 20
Woodbridge 20
Brussels 18
Nürnberg 18
Helsinki 16
Los Angeles 16
Seattle 16
Falls Church 15
Marseille 15
Princeton 15
Redwood City 15
Shanghai 14
Abidjan 13
Boardman 13
Redmond 13
Augusta 11
Beijing 10
Hefei 10
Brno 9
Cambridge 9
Lawrence 9
Hangzhou 8
Izmir 8
Nanchang 8
Seoul 8
Chennai 7
Frankfurt am Main 7
Istanbul 7
Munich 7
Santa Clara 7
Zurich 7
Bari 6
Düsseldorf 6
Kish 6
Mountain View 6
São Paulo 6
Fremont 5
Gandhinagar 5
Hebei 5
London 5
Norwalk 5
Nuremberg 5
Petrozavodsk 5
Andover 4
Bremen 4
Hong Kong 4
Kunming 4
Lappeenranta 4
Lauterbourg 4
Naples 4
Newark 4
San Diego 4
Shenyang 4
Vienna 4
Bexley 3
Bologna 3
Busto Arsizio 3
Changsha 3
Foggia 3
Leawood 3
Mexico City 3
Miami 3
Mumbai 3
Noida 3
North Bergen 3
Northbrook 3
Oliveira de Azeméis 3
Pune 3
San Francisco 3
Trento 3
Birmingham 2
Brooklyn 2
Ceglie Messapica 2
Curitiba 2
Curti 2
Dong Ket 2
Englewood 2
Gurgaon 2
Totale 1.646
Nome #
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 260
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 215
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 190
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 159
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 137
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 120
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 117
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 116
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 110
Enhanced recovery after surgery (ERAS) versus standard recovery for gastric cancer patients: The evidences and the issues: ERAS and Gastric Cancer 103
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 97
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 90
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 89
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 84
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 82
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 80
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 80
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 79
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 78
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 77
The Role of Surgery in the Management of Gastric Cancer: State of the Art 71
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 69
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 68
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 68
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 68
Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new? 66
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 62
The Role of Staging Laparoscopy for Gastric Cancer Patients: Current Evidence and Future Perspectives 60
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 57
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 47
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments 28
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 21
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 20
Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis 18
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 2
Totale 3.088
Categoria #
all - tutte 13.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 0 0 0 0 0 0 58 30
2020/2021225 6 25 40 9 21 11 16 1 31 20 38 7
2021/2022437 57 18 14 71 16 15 8 55 17 27 55 84
2022/2023670 102 86 37 109 28 80 39 49 41 26 22 51
2023/2024424 18 80 12 11 10 68 38 23 21 20 33 90
2024/2025678 22 29 69 25 72 32 39 33 98 105 154 0
Totale 3.088